IL6 and atherosclerosis: For patients with inflammation driven by pathways other than NLRP3, hsCRP may not be elevated.32 Other markers, such as IL-6, are likely causally linked to ASCVD but are not yet clinically applicable due to difficulties in measurement and standardization.